GEM-22X Trademark

Trademark Overview

On Monday, September 16, 2019, a trademark application was filed for GEM-22X with the United States Patent and Trademark Office. The USPTO has given the GEM-22X trademark a serial number of 88618494. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 17, 2023. This trademark is owned by Lynch Biologics, LLC. The GEM-22X trademark is filed in the Pharmaceutical Products category with the following description:

Natural biomaterials for augmentation of bone and tissue for medical purposes; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Xenograft tissue
gem-22x

General Information

Serial Number88618494
Word MarkGEM-22X
Filing DateMonday, September 16, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2020

Trademark Statements

Goods and ServicesNatural biomaterials for augmentation of bone and tissue for medical purposes; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Xenograft tissue

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 24, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLynch Biologics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressFranklin, TN 37064
Party NameLynch Biologics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFranklin, TN 37064

Trademark Events

Event DateEvent Description
Monday, April 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 17, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, September 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 27, 2022SOU EXTENSION 5 GRANTED
Tuesday, September 13, 2022SOU EXTENSION 5 FILED
Tuesday, September 27, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 13, 2022TEAS EXTENSION RECEIVED
Saturday, March 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 17, 2022SOU EXTENSION 4 GRANTED
Thursday, March 17, 2022SOU EXTENSION 4 FILED
Thursday, March 17, 2022TEAS EXTENSION RECEIVED
Wednesday, September 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 13, 2021SOU EXTENSION 3 GRANTED
Monday, September 13, 2021SOU EXTENSION 3 FILED
Monday, September 13, 2021TEAS EXTENSION RECEIVED
Thursday, January 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 18, 2021SOU EXTENSION 2 GRANTED
Monday, January 18, 2021SOU EXTENSION 2 FILED
Monday, January 18, 2021TEAS EXTENSION RECEIVED
Saturday, September 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 17, 2020SOU EXTENSION 1 GRANTED
Thursday, September 17, 2020SOU EXTENSION 1 FILED
Thursday, September 17, 2020TEAS EXTENSION RECEIVED
Tuesday, March 17, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 16, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 16, 2019ASSIGNED TO EXAMINER
Tuesday, September 24, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 19, 2019NEW APPLICATION ENTERED

Related Keywords

tissue treatment substances damaged xenograft skin preparations purposes augmentation biomaterials